Home › Acute Myeloid Leukemia › Georgia › Augusta
Acute Myeloid Leukemia clinical trials in Augusta, GA
10 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Augusta University Medical Center, Augusta
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Augusta University Medical Center, Augusta
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Augusta University Medical Center, Augusta
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Augusta University Medical Center, Augusta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- Augusta University Medical Center, Augusta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Georgia Cancer Center at Augusta University, Augusta
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
RecruitingPhase 2/3
- Augusta University - Georgia Cancer Center, Augusta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Georgia Cancer Center at Augusta University Health, Augusta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Georgia Cancer Center at Augusta University, Augusta
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
RecruitingPhase 2
- Georgia Cancer Center at Augusta University, Augusta
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX86 studies
- New York City, NY51 studies
- Boston, MA45 studies
- Baldwin Park, CA40 studies
- Seattle, WA40 studies
- Columbus, OH34 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Tampa, FL29 studies
- Atlanta, GA29 studies
- Chicago, IL27 studies
- Portland, OR25 studies
Other studies in Augusta
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Endometrial Cancer7 studies
- Blood Cancers5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Cervical Cancer4 studies
- Myasthenia Gravis4 studies
- Non-Hodgkin Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Burkitt Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.